Hepatatox Liquid
NDC Package 43857-0543-1
Package Information
Hepatatox (triticum aestivum, chelidonium majus, taraxacum officinale, glutathione, hepar suis, thyroidinum (suis), lycopodium clavatum, nux vomica, phosphoricum acidum, adrenocorticotrophin, salicylicum acidum, cortisone aceticum, eugenol, stearyl alcohol, xylitol, folliculinum, benzoicum acidum, chlorinum potassium sorbate, sorbitol, resorcinum, benzyl alcohol, lacticum acidum, isopropyl palmitate, boricum acidum, aceticum acidum, phenyl butazone, petroleum jelly, plumbum metallicum) liquids is for temporary relief of dyspepsia, flatulence, exhaustion, and nausea as a consequence of constipation. This formulation utilizes a liquid delivery system. Marketed by Bioactive Nutritional, Inc, this product is identified by NDC 43857-0543.
Identification & Billing
Clinical Specifications
- TRITICUM AESTIVUM WHOLE 30 [hp_X]/mL
- CHELIDONIUM MAJUS WHOLE 30 [hp_X]/mL
- TARAXACUM OFFICINALE 30 [hp_X]/mL
- GLUTATHIONE 30 [hp_X]/mL
- PORK LIVER 3 [hp_X]/mL
- THYROID 30 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 30 [hp_C]/mL
- STRYCHNOS NUX-VOMICA SEED 30 [hp_X]/mL
- PHOSPHORIC ACID 30 [hp_X]/mL
- CORTICOTROPIN 30 [hp_X]/mL
- SALICYLIC ACID 6 [hp_X]/mL
- CORTISONE ACETATE 30 [hp_X]/mL
- EUGENOL 30 [hp_X]/mL
- STEARYL ALCOHOL 30 [hp_X]/mL
- XYLITOL 12 [hp_X]/mL
- ESTRONE 30 [hp_X]/mL
- BENZOIC ACID 30 [hp_X]/mL
- CHLORINE 12 [hp_X]/mL
- POTASSIUM SORBATE 8 [hp_X]/mL
- SORBITOL 30 [hp_X]/mL
- RESORCINOL 30 [hp_X]/mL
- BENZYL ALCOHOL 30 [hp_X]/mL
- LACTIC ACID, DL- 30 [hp_X]/mL
- ISOPROPYL PALMITATE 30 [hp_X]/mL
- BORIC ACID 12 [hp_X]/mL
- ACETIC ACID 3 [hp_X]/mL
- PHENYLBUTAZONE 8 [hp_X]/mL
- PETROLATUM 1 [hp_X]/mL
- LEAD 30 [hp_X]/mL
- Adrenocorticotropic Hormone - [CS]
- Adrenocorticotropic Hormone - [EPC] (Established Pharmacologic Class)
- Allergens - [CS]
- Ammonium Ion Binding Activity - [MoA] (Mechanism of Action)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Nitrogen Binding Agent - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Pediculicide - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 43857 - Bioactive Nutritional, Inc
- 43857-0543 - Hepatatox
- 43857-0543-1 - 30 mL in 1 BOTTLE, DROPPER
- 43857-0543 - Hepatatox
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43857-0543-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Hepatatox, a human over the counter drug labeled by Bioactive Nutritional, Inc. This liquid is formulated for oral use and contains triticum aestivum whole; chelidonium majus whole; taraxacum officinale; glutathione; pork liver; thyroid; lycopodium clavatum spore; strychnos nux-vomica seed; phosphoric acid; corticotropin; salicylic acid; cortisone acetate; eugenol; stearyl alcohol; xylitol; estrone; benzoic acid; chlorine; potassium sorbate; sorbitol; resorcinol; benzyl alcohol; lactic acid, dl-; isopropyl palmitate; boric acid; acetic acid; phenylbutazone; petrolatum; lead as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioactive Nutritional, Inc on February 20, 2020. The current certification is valid through December 31, 2026.
How is this Bioactive Nutritional, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43857054301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.